Horm Metab Res 2012; 44(11): 819-824
DOI: 10.1055/s-0032-1321909
Original Basic
© Georg Thieme Verlag KG Stuttgart · New York

Ginsenoside-Rb1 Promotes Adipogenesis Through Regulation of PPARγ and MicroRNA-27b

L.-S. Chan*
1   Department of Biology, Faculty of Science, Hong Kong Baptist University, Hong Kong
,
P. Y.-K. Yue*
1   Department of Biology, Faculty of Science, Hong Kong Baptist University, Hong Kong
,
T.-W. Kok
1   Department of Biology, Faculty of Science, Hong Kong Baptist University, Hong Kong
,
M.-H. Keung
1   Department of Biology, Faculty of Science, Hong Kong Baptist University, Hong Kong
,
N.-K. Mak
1   Department of Biology, Faculty of Science, Hong Kong Baptist University, Hong Kong
,
R. N.-S. Wong
1   Department of Biology, Faculty of Science, Hong Kong Baptist University, Hong Kong
› Author Affiliations
Further Information

Publication History

received 31 January 2012

accepted after second revision 10 July 2012

Publication Date:
14 August 2012 (online)

Abstract

Ginsenoside-Rb1 (Rb1), one of the bioactive components in ginseng extract, is recently reported to be able to promote adipogenesis and peroxisome proliferator-activated receptor gamma (PPARγ) expression. Meanwhile, microRNA-27b (miR-27b) is also identified to regulate adipogenesis by targeting PPARγ2. In the present study, we attempted to link up the Rb1-promoted adipogenesis with PPARγ binding and miR-27b regulation. First, we demonstrated that GW9662, an antagonist of PPARγ, could block Rb1-induced 3T3-L1 differentiation with little toxicity towards cell proliferation. Then, expression levels for both of miR-27b and its primary transcript, pri-mir-27b, were found to decrease upon Rb1 treatment. Again, GW9662 could attenuate the inhibitory effect of Rb1 on both miR-27 and pri-mir-27b expression. Since Rb1 was demonstrated to have binding activity towards PPARγ, we thus speculate that Rb1 may act though PPARγ to downregulate mir-27b gene transcription and mature miR-27b activity, which in turn promotes PPARγ expression and adipogenesis. Enhancement on adipogenesis of adipose tissues is expected to prevent lipotoxicty in nonadipose tissues. Our data may give a better illustration to explain the antidiabetic effect of Rb1 and provide a hint on treatment of lipid related metabolic diseases in the future.

*

*  These authors contributed equally to this manuscript.


 
  • References

  • 1 Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. Transcriptional regulation of adipogenesis. Genes Dev 2000; 14: 1293-1307
  • 2 World Health Organization Diabetes. Fact sheet #312 2011 (online document http://www.who.int/mediacentre/factsheets/fs312/en/)
  • 3 Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev 1998; 78: 783-809
  • 4 Yun TK. Brief introduction of Panax ginseng C.A. Meyer. J. Korean Med Sci 2001; 16 (Suppl) S3-S5
  • 5 Liu CX, Xiao PG. Recent advances on ginseng research in China. J Ethnopharmacol 1992; 36: 27-38
  • 6 Xie JT, Wang CZ, Wang AB, Wu J, Basila D, Yuan CS. Antihyperglycemic effects of total ginsenosides from leaves and stem of Panax ginseng. Acta Pharmacol Sin 2005; 26: 1104-1110
  • 7 Shang W, Yang Y, Jiang B, Jin H, Zhou L, Liu S, Chen M. Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPARgamma2 and C/EBPalpha gene expression. Life Sci 2007; 80: 618-625
  • 8 Shang W, Yang Y, Zhou L, Jiang B, Jin H, Chen M. Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes. J Endocrinol 2008; 198: 561-569
  • 9 Xiong Y, Shen L, Liu KJ, Tso P, Xiong Y, Wang G, Woods SC, Liu M. Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes 2010; 59: 2505-2512
  • 10 Lai DM, Tu YK, Liu IM, Chen PF, Cheng JT. Medication of beta-endorphin by ginsenoside Rh2 to lower plasma glucose in streptozotocin induced diabetic rats. Planta Medica 2006; 1: 9-13
  • 11 Lee WK, Koa ST, Liu IM, Cheng JT. Ginsenoside Rh2 is one of the active principle of Panax ginseng root to improve insulin sensitivity in fructose –rich chow-fed rats. Horm Metab Res 2007; 39: 347-354
  • 12 Wang Y, Wang H, Liu Y, Li C, Qi P, Bao J. Antihyperglycemic effect of ginsenoside Rh2 by inducing islet β-cell regeneration in mice. Horm Metab Res 2012; 44: 33-40
  • 13 Krützfeldt J, Stoffel M. MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab 2006; 4: 9-12
  • 14 Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297
  • 15 Sevignani C, Calin GA, Siracusa LD, Croce CM. Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome 2006; 17: 189-202
  • 16 Karbiener M, Fischer C, Nowitsch S, Opriessnig P, Papak C, Ailhaud G, Dani C, Amri EZ, Scheideler M. MicroRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem Biophys Res Commun 2009; 390: 247-251
  • 17 Lin Q, Gao Z, Alarcon RM, Ye J, Yun Z. A role of miR-27 in the regulation of adipogenesis. FEBS J 2009; 276: 2348-2358
  • 18 Feng J, Iwama A, Satake M, Kohu K. MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post-transcriptionally downregulating Runx1. Br J Haematol 2009; 145: 412-423
  • 19 Farmer SR. Transcriptional control of adipocyte formation. Cell Metab 2006; 4: 263-273
  • 20 Kwok KC, Cheung NH. Measuring binding kinetics of ligands with tethered receptors by fluorescence polarization and total internal reflection fluorescence. Anal Chem 2010; 82: 3819-3825
  • 21 Chen W, Dang Y, Zhu C. Simultaneous determination of three major bioactive saponins of Panax notoginseng using liquid chromatography-tandem mass spectrometry and a pharmacokinetic study. Chin Med 2010; 5: 12-17
  • 22 Xiong J, Guo J, Huang L, Meng B, Ping Q. The use of lipid-based formulations to increase the oral bioavailability of Panax notoginseng saponins following a single oral gavage to rats. Drug Dev Ind Pharm 2008; 34: 65-72